查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538506

胃蛋白酶市場報告：2030 年趨勢、預測與競爭分析

Pepsin Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

胃蛋白酶趨勢與預測

預計2024年至2030年全球胃蛋白酶市場將以3.2%的複合年成長率成長。該市場的主要驅動力是生活方式的顯著變化和女性工人數量的成長。全球胃蛋白酶市場前景廣闊，保健補充品市場和藥品市場充滿機會。

胃蛋白酶按細分市場

該報告按類型、最終用途和地區預測了全球胃蛋白酶市場。

胃蛋白酶市場洞察

Lucintel預測，高活躍度（1:10000以上）可望在預測期內實現高成長。

在這個市場中，保健補充品預計將出現更高的成長。

由於對提高生活品質的有效藥物的需求不斷增加，預計北美在預測期內將出現最高的成長。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球胃蛋白酶市場預計將以3.2%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2.該市場的主要促進因素是生活方式的顯著變化和女性工人數量的增加。

Q3.市場的主要細分市場是：

A3. 胃蛋白酶市場前景廣闊，保健補充品市場及醫藥市場充滿機會。

Q4.市場的主要企業是：

A4. 主要胃蛋白酶公司如下：

  • Chongqing Jingkang Biotechnology
  • Feideli Pharmaceutical
  • Sichuan Deebio Pharmaceutical
  • Biozyme
  • Kin Master
  • Sichuan Biosyn Pharmaceutical
  • A. Constantino and C

Q5.未來最大的細分市場是什麼？

A5.Lucintel預測，高活躍度（1:10000以上）將在預測期內出現高成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於對提高生活品質的有效藥物的需求不斷增加，預計北美在預測期內將出現最高的成長。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球胃蛋白酶市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球胃蛋白酶市場趨勢（2018-2023）與預測（2024-2030）
  • 全球胃蛋白酶市場（按類型）
    • 高活性（1：10000以上）
    • 低活性（小於1：10000）
  • 全球胃蛋白酶市場（按最終用途）
    • 保健補充品
    • 藥品
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的胃蛋白酶市場
  • 北美胃蛋白酶市場
  • 歐洲胃蛋白酶市場
  • 亞太胃蛋白酶市場
  • 其他地區胃蛋白酶市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球胃蛋白酶市場的成長機會（按類型）
    • 全球胃蛋白酶市場成長機會（依最終用途）
    • 按地區分類的全球胃蛋白酶市場成長機會
  • 全球胃蛋白酶市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球胃蛋白酶市場產能
    • 全球胃蛋白酶市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Chongqing Jingkang Biotechnology
  • Feideli Pharmaceutical
  • Sichuan Deebio Pharmaceutical
  • Biozyme
  • Kin Master
  • Sichuan Biosyn Pharmaceutical
  • A. Constantino and C
簡介目錄

Pepsin Trends and Forecast

The future of the global pepsin market looks promising with opportunities in the health supplement and pharmaceutical markets. The global pepsin market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are significant shift in lifestyle and rise in the population of employed women.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Pepsin by Segment

The study includes a forecast for the global pepsin by type, end use, and region.

Pepsin Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • High Activity (min. 1:10000)
  • Low Activity (below 1:10000)

Pepsin Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Health Supplements
  • Pharmaceuticals
  • Others

Pepsin Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pepsin Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pepsin companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pepsin companies profiled in this report include-

  • Chongqing Jingkang Biotechnology
  • Feideli Pharmaceutical
  • Sichuan Deebio Pharmaceutical
  • Biozyme
  • Kin Master
  • Sichuan Biosyn Pharmaceutical
  • A. Constantino and C

Pepsin Market Insights

Lucintel forecasts that high activity (min. 1:10000) is expected to witness higher growth over the forecast period.

Within this market, health supplement is expected to witness higher growth.

North America is expected to witness the highest growth over the forecast period due to growing demand for effective medications to enhance the quality of life.

Features of the Global Pepsin Market

Market Size Estimates: Pepsin market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pepsin market size by type, end use, and region in terms of value ($B).

Regional Analysis: Pepsin market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the pepsin market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pepsin market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for pepsin market?

Answer: The global pepsin market is expected to grow with a CAGR of 3.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the pepsin market?

Answer: The major drivers for this market are significant shift in lifestyle and rise in the population of employed women.

Q3. What are the major segments for pepsin market?

Answer: The future of the pepsin market looks promising with opportunities in the health supplement and pharmaceutical markets.

Q4. Who are the key pepsin market companies?

Answer: Some of the key pepsin companies are as follows:

  • Chongqing Jingkang Biotechnology
  • Feideli Pharmaceutical
  • Sichuan Deebio Pharmaceutical
  • Biozyme
  • Kin Master
  • Sichuan Biosyn Pharmaceutical
  • A. Constantino and C

Q5. Which pepsin market segment will be the largest in future?

Answer: Lucintel forecasts that high activity (min. 1:10000) is expected to witness higher growth over the forecast period.

Q6. In pepsin market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period due to growing demand for effective medications to enhance the quality of life.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pepsin market by type (high activity (min. 1:10000) and low activity (below 1:10000)), end use (health supplements, pharmaceuticals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pepsin Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pepsin Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pepsin Market by Type
    • 3.3.1: High Activity (min. 1:10000)
    • 3.3.2: Low Activity (below 1:10000)
  • 3.4: Global Pepsin Market by End Use
    • 3.4.1: Health Supplements
    • 3.4.2: Pharmaceuticals
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pepsin Market by Region
  • 4.2: North American Pepsin Market
    • 4.2.1: North American Pepsin Market by Type: High Activity (min. 1:10000) and Low Activity (below 1:10000)
    • 4.2.2: North American Pepsin Market by End Use: Health Supplements, Pharmaceuticals, and Others
  • 4.3: European Pepsin Market
    • 4.3.1: European Pepsin Market by Type: High Activity (min. 1:10000) and Low Activity (below 1:10000)
    • 4.3.2: European Pepsin Market by End Use: Health Supplements, Pharmaceuticals, and Others
  • 4.4: APAC Pepsin Market
    • 4.4.1: APAC Pepsin Market by Type: High Activity (min. 1:10000) and Low Activity (below 1:10000)
    • 4.4.2: APAC Pepsin Market by End Use: Health Supplements, Pharmaceuticals, and Others
  • 4.5: ROW Pepsin Market
    • 4.5.1: ROW Pepsin Market by Type: High Activity (min. 1:10000) and Low Activity (below 1:10000)
    • 4.5.2: ROW Pepsin Market by End Use: Health Supplements, Pharmaceuticals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pepsin Market by Type
    • 6.1.2: Growth Opportunities for the Global Pepsin Market by End Use
    • 6.1.3: Growth Opportunities for the Global Pepsin Market by Region
  • 6.2: Emerging Trends in the Global Pepsin Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pepsin Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pepsin Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Chongqing Jingkang Biotechnology
  • 7.2: Feideli Pharmaceutical
  • 7.3: Sichuan Deebio Pharmaceutical
  • 7.4: Biozyme
  • 7.5: Kin Master
  • 7.6: Sichuan Biosyn Pharmaceutical
  • 7.7: A. Constantino and C